The Biomarker Research Services Market - Introduction

Biomarkers are key molecular or cellular events that are used to link a specific environmental exposure to a health outcome or target disease. Biomarkers play an important role in understanding the development of chronic human diseases and identification of subgroups that are at increased risk for disease. In the past few years, biomarkers have been extensively used in all therapeutic areas of medicine to diagnose a particular disease. Biomarkers are used for drug approval process as included in the regulatory submission processes.

Biomarker research services are specifically provided for development and validation of new biomarkers. These services are provided for different purposes such as research assay, biomarker validation & discovery of a biomarker, qualification, verification, optimization, and companion diagnostics. Companion diagnostic (CDx) is a medical device or test used for a therapeutic drug to determine and validate its drug applicability in specific person, its safety, risk, and benefit from that drug.

The Biomarker Research Services Market – Competitive Landscape

The global biomarker research services market is highly fragmented due to presence of major companies and CROs. Key players operating in the global market include Noble Life Sciences, Inc., REPROCELL USA, Inc., BioIVT, Covance, Inc., PointCross Life Sciences, Coriell Institute, SRI International, ICON plc, Nordic Bioscience, and Proteome Sciences plc.

Identify the key factors that will drive your company’s growth. Request a brochure of this report here

Merger & acquisition, collaboration, strategic alliances, partnerships, and new product offerings are the key strategies adopted by the major companies.

  • On 25 March 2019, BioIVT joined the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium to develop and support research to qualify promising biomarkers for diagnosing diseases, predicting therapeutic response, or improving clinical practice.

Noble Life Sciences, Inc.                                  

Founded in 2010, Noble Life Sciences, Inc. is headquartered in U.S. Noble Life Sciences, Inc. is a contract research organization (CRO) which offers in-vitro and in-vivo preclinical drug development services. Company also offers standard GLP and non-GLP services which involves safety & efficacy testing for the development of drugs, vaccines and medical devices. Biomarker discovery & validation, molecular tumor profiling, and clinical biomarker development & implementation services are some of the major services provided by company.

REPROCELL USA, Inc.                                     

Established in 2003, REPROCELL USA, Inc. is headquartered at Yokohama, Japan. REPROCELL USA, Inc. is a global company located at U.S., Europe, Japan and India. Company services include BioServe, predictive drug discovery custom services, stem cell culture media and reprogramming technologies.

In April 2017, REPROCELL and Fox Chase Cancer Center announced a strategic alliance aimed at accelerating oncology discovery and translational studies. This alliance aimed to accelerate biomarker and genetic discovery.

BioIVT

Founded in 1981, BioIVT is based in U.S. Company provides value-added services such as biomarker target & validation, precision medicine research and phenotypic assays. Company has acquired various other organizations to enhance its presence and services offered.

In August 2017, BioIVT acquired Asterand Bioscience, which focused on drug research by biomarker validation and target identification.

Covance, Inc.                                                      

Established in 1996, Covance, Inc. is headquartered at Princeton, U.S. Covance, Inc. is a contract research organization and was acquired by Laboratory Corporation of America Holdings in 2014. Company offers nonclinical, preclinical and clinical services to pharmaceutical, and biotechnology companies for drug development, clinical testing, regulatory services and safety & toxicology studies.

Expanding operations in future? To get the perfect launch ask for a custom report here

Biomarker Research Services Market - Dynamics

Rise in prevalence of chronic diseases and growing use of biomarkers in diagnostic therapeutic areas driving the market

Increasing use of biomarkers in diagnostic therapeutic and rise in prevalence of chronic diseases across the world are the major factors boosting the growth of the global biomarker research services market. According to the WHO, cancer accounted for an estimated 9.6 million deaths and was the second major cause of death globally in 2018. Moreover, about 1 in 6 deaths occur due to cancer globally.

Major merger, acquisitions and strategic partnerships by major players to drive the global market

Mergers & acquisitions and strategic partnerships by key players are fueling the growth of the global biomarker research services market. Moreover, increase in therapeutic areas of companion diagnostics in personalized medicine is attributed to the growth of the global biomarker research services market. In April 2017, Bristol-Myers Squibb and Nordic Bioscience announced a collaboration agreement for biomarker development technology to potentially aid in the diagnosis and monitoring of fibrotic diseases.

Higher cost for research and incapability of pharmaceutical & biotechnology companies restraining biomarker research services market growth

Incapability of pharmaceutical & biotechnology companies to conduct biomarker research and higher cost for research are the factors likely to hamper the growth of the global biomarker research services market. Higher research cost for new drug development and drug discovery is hampering the growth of global biomarker research services market.

North America Biomarker research services market- Dominating region

North America dominated the global market in 2018 and is projected to sustain its position during the forecast period. Higher demand of biomarkers for disease diagnosis, companion diagnostic research for new drug development, rise in prevalence of chronic diseases, presence of major players engaged in mergers & acquisitions, collaboration with CROs for biomarkers, and rise in investment for R&D by companies are the major factors driving the biomarker research services market in North America.

Biomarker Research Services Market - Segmentation

The global biomarker research services market can be segmented on the basis of:

  • Service Type
  • Therapeutic Area
  • End-user
  • Region

Biomarker Research Services Market Segmentation – By Service Type

Depending on the service type, the biomarker research services market can be divided into:

  • Biomarker Research Services
  • Companion Diagnostic Research Services

Biomarker Research Services Market Segmentation – By Therapeutic Area

Based on the therapeutic area, the biomarker research services market can be divided into:

  • Oncology
  • Cardiovascular Diseases
  • Neurological Disorders
  • Immunological Diseases
  • Others

Biomarker Research Services Market Segmentation – By End-user

In terms of end-user, the biomarker research services market can be divided into:

  • Hospitals & specialty clinics
  • Diagnostic Centers
  • Pharmaceutical & biotechnology companies
  • Others

The report on biomarker research services market is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The biomarker research services market report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The biomarker research services market report also maps the qualitative impact of various market factors on biomarker research services market segments and geographies.

Regional analysis for biomarker research services market includes:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

.